Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Payment Parity for Telehealth Linked to Better BP Treatment

Michael O'Riordan

August 07, 2024

News Daily News

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

Michael O'Riordan

July 29, 2024

News Opinion CV Team Dispatch

December 2023 Dispatch for the CV Team

L.A. McKeown

December 01, 2023

News Opinion CV Team Dispatch

November 2023 News Roundup

L.A. McKeown

November 01, 2023

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

L.A. McKeown

August 18, 2023

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Opinion Editor's Corner EuroPCR 2022

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Shelley Wood

May 12, 2022

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

April 2025 Dispatch for the CV Team

March 2025 Dispatch for the CV Team

Payment Parity for Telehealth Linked to Better BP Treatment

AAA-Related Mortality Rates Decline, With Reductions Seen in All Groups

December 2023 Dispatch for the CV Team

November 2023 News Roundup

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 2023 News Roundup

As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Registry Data Hint at MACE Benefit With Renal Denervation

EuroPCR Kicks Off In Person Next Week in Paris: Here’s What to Expect

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content